nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—HTR1B—obesity	0.194	0.598	CbGaD
Sumatriptan—MAOA—Phentermine—obesity	0.132	0.351	CbGbCtD
Sumatriptan—DRD2—obesity	0.13	0.402	CbGaD
Sumatriptan—MAOA—Phenylpropanolamine—obesity	0.126	0.335	CbGbCtD
Sumatriptan—MAOA—Methamphetamine—obesity	0.105	0.28	CbGbCtD
Sumatriptan—HTR3A—area postrema—obesity	0.0151	0.385	CbGeAlD
Sumatriptan—ABCB1—Cimetidine—obesity	0.0129	0.0345	CbGbCtD
Sumatriptan—HTR3A—vagus nerve—obesity	0.00502	0.128	CbGeAlD
Sumatriptan—HTR1A—hindbrain—obesity	0.000994	0.0254	CbGeAlD
Sumatriptan—HTR3A—islet of Langerhans—obesity	0.00095	0.0243	CbGeAlD
Sumatriptan—MAOA—hindbrain—obesity	0.000908	0.0232	CbGeAlD
Sumatriptan—DRD2—hindbrain—obesity	0.000898	0.023	CbGeAlD
Sumatriptan—HTR3A—respiratory system—obesity	0.000897	0.0229	CbGeAlD
Sumatriptan—Naratriptan—HTR1B—obesity	0.000671	0.216	CrCbGaD
Sumatriptan—MAOA—islet of Langerhans—obesity	0.000587	0.015	CbGeAlD
Sumatriptan—HTR1B—cardiovascular system—obesity	0.000576	0.0147	CbGeAlD
Sumatriptan—HTR3A—digestive system—obesity	0.00057	0.0146	CbGeAlD
Sumatriptan—HTR1D—cardiovascular system—obesity	0.000558	0.0143	CbGeAlD
Sumatriptan—Rizatriptan—HTR1B—obesity	0.000556	0.179	CrCbGaD
Sumatriptan—MAOA—respiratory system—obesity	0.000555	0.0142	CbGeAlD
Sumatriptan—SLCO1B1—digestive system—obesity	0.000553	0.0141	CbGeAlD
Sumatriptan—DRD2—respiratory system—obesity	0.000549	0.014	CbGeAlD
Sumatriptan—Zolmitriptan—HTR1B—obesity	0.000508	0.164	CrCbGaD
Sumatriptan—MAOA—adrenal cortex—obesity	0.000465	0.0119	CbGeAlD
Sumatriptan—HTR1A—cardiovascular system—obesity	0.000465	0.0119	CbGeAlD
Sumatriptan—SLCO1B1—endocrine gland—obesity	0.000457	0.0117	CbGeAlD
Sumatriptan—SLCO1A2—digestive system—obesity	0.00045	0.0115	CbGeAlD
Sumatriptan—MAOA—cardiovascular system—obesity	0.000425	0.0109	CbGeAlD
Sumatriptan—SLCO1B1—liver—obesity	0.000412	0.0105	CbGeAlD
Sumatriptan—ABCG2—adrenal cortex—obesity	0.000404	0.0103	CbGeAlD
Sumatriptan—HTR1B—endocrine gland—obesity	0.000395	0.0101	CbGeAlD
Sumatriptan—Almotriptan—HTR1B—obesity	0.000385	0.124	CrCbGaD
Sumatriptan—MAOA—pituitary gland—obesity	0.000376	0.00962	CbGeAlD
Sumatriptan—MAOA—adipose tissue—obesity	0.000375	0.00958	CbGeAlD
Sumatriptan—DRD2—pituitary gland—obesity	0.000372	0.00951	CbGeAlD
Sumatriptan—SLCO1A2—endocrine gland—obesity	0.000372	0.00951	CbGeAlD
Sumatriptan—HTR1A—adrenal gland—obesity	0.000368	0.00941	CbGeAlD
Sumatriptan—MAOA—digestive system—obesity	0.000353	0.00902	CbGeAlD
Sumatriptan—MAOA—adrenal gland—obesity	0.000336	0.00859	CbGeAlD
Sumatriptan—SLCO1A2—liver—obesity	0.000335	0.00857	CbGeAlD
Sumatriptan—ABCG2—pituitary gland—obesity	0.000326	0.00834	CbGeAlD
Sumatriptan—ABCG2—adipose tissue—obesity	0.000325	0.00831	CbGeAlD
Sumatriptan—HTR1A—endocrine gland—obesity	0.000319	0.00816	CbGeAlD
Sumatriptan—Eletriptan—HTR1B—obesity	0.0003	0.0967	CrCbGaD
Sumatriptan—MAOA—endocrine gland—obesity	0.000291	0.00745	CbGeAlD
Sumatriptan—ABCG2—adrenal gland—obesity	0.000291	0.00745	CbGeAlD
Sumatriptan—DRD2—endocrine gland—obesity	0.000288	0.00737	CbGeAlD
Sumatriptan—MAOA—liver—obesity	0.000263	0.00672	CbGeAlD
Sumatriptan—ABCB1—islet of Langerhans—obesity	0.000251	0.00642	CbGeAlD
Sumatriptan—Almotriptan—CYP2E1—obesity	0.000249	0.0803	CrCbGaD
Sumatriptan—ABCB1—respiratory system—obesity	0.000237	0.00606	CbGeAlD
Sumatriptan—ABCG2—liver—obesity	0.000228	0.00582	CbGeAlD
Sumatriptan—Melatonin—CYP19A1—obesity	0.000226	0.0727	CrCbGaD
Sumatriptan—Melatonin—ESR1—obesity	0.000208	0.0669	CrCbGaD
Sumatriptan—ABCB1—adrenal cortex—obesity	0.000199	0.00509	CbGeAlD
Sumatriptan—ABCB1—cardiovascular system—obesity	0.000182	0.00464	CbGeAlD
Sumatriptan—ABCB1—pituitary gland—obesity	0.000161	0.00411	CbGeAlD
Sumatriptan—ABCB1—adipose tissue—obesity	0.00016	0.0041	CbGeAlD
Sumatriptan—ABCB1—digestive system—obesity	0.000151	0.00386	CbGeAlD
Sumatriptan—ABCB1—adrenal gland—obesity	0.000144	0.00367	CbGeAlD
Sumatriptan—ABCB1—endocrine gland—obesity	0.000125	0.00319	CbGeAlD
Sumatriptan—ABCB1—liver—obesity	0.000112	0.00287	CbGeAlD
Sumatriptan—Tinnitus—Bupropion—obesity	9.45e-05	0.000616	CcSEcCtD
Sumatriptan—Malaise—Orlistat—obesity	9.43e-05	0.000614	CcSEcCtD
Sumatriptan—Flushing—Bupropion—obesity	9.41e-05	0.000613	CcSEcCtD
Sumatriptan—Vertigo—Orlistat—obesity	9.39e-05	0.000612	CcSEcCtD
Sumatriptan—Ill-defined disorder—Sibutramine—obesity	9.39e-05	0.000612	CcSEcCtD
Sumatriptan—Anaemia—Sibutramine—obesity	9.35e-05	0.000609	CcSEcCtD
Sumatriptan—Diplopia—Topiramate—obesity	9.33e-05	0.000608	CcSEcCtD
Sumatriptan—Osteoarthritis—Topiramate—obesity	9.33e-05	0.000608	CcSEcCtD
Sumatriptan—Agitation—Sibutramine—obesity	9.3e-05	0.000606	CcSEcCtD
Sumatriptan—Angioedema—Sibutramine—obesity	9.25e-05	0.000602	CcSEcCtD
Sumatriptan—Palpitations—Orlistat—obesity	9.24e-05	0.000602	CcSEcCtD
Sumatriptan—Angiopathy—Bupropion—obesity	9.19e-05	0.000599	CcSEcCtD
Sumatriptan—Migraine—Topiramate—obesity	9.19e-05	0.000598	CcSEcCtD
Sumatriptan—Nausea—Cimetidine—obesity	9.18e-05	0.000598	CcSEcCtD
Sumatriptan—Immune system disorder—Bupropion—obesity	9.15e-05	0.000596	CcSEcCtD
Sumatriptan—Mediastinal disorder—Bupropion—obesity	9.13e-05	0.000595	CcSEcCtD
Sumatriptan—Malaise—Sibutramine—obesity	9.13e-05	0.000595	CcSEcCtD
Sumatriptan—Cough—Orlistat—obesity	9.12e-05	0.000594	CcSEcCtD
Sumatriptan—Chills—Bupropion—obesity	9.09e-05	0.000592	CcSEcCtD
Sumatriptan—Vertigo—Sibutramine—obesity	9.09e-05	0.000592	CcSEcCtD
Sumatriptan—Syncope—Sibutramine—obesity	9.08e-05	0.000591	CcSEcCtD
Sumatriptan—Convulsion—Orlistat—obesity	9.06e-05	0.00059	CcSEcCtD
Sumatriptan—Arrhythmia—Bupropion—obesity	9.05e-05	0.00059	CcSEcCtD
Sumatriptan—Palpitations—Sibutramine—obesity	8.94e-05	0.000583	CcSEcCtD
Sumatriptan—Chest pain—Orlistat—obesity	8.9e-05	0.00058	CcSEcCtD
Sumatriptan—Myalgia—Orlistat—obesity	8.9e-05	0.00058	CcSEcCtD
Sumatriptan—Loss of consciousness—Sibutramine—obesity	8.89e-05	0.000579	CcSEcCtD
Sumatriptan—Anxiety—Orlistat—obesity	8.87e-05	0.000578	CcSEcCtD
Sumatriptan—Cough—Sibutramine—obesity	8.83e-05	0.000575	CcSEcCtD
Sumatriptan—Discomfort—Orlistat—obesity	8.8e-05	0.000573	CcSEcCtD
Sumatriptan—Convulsion—Sibutramine—obesity	8.77e-05	0.000571	CcSEcCtD
Sumatriptan—Hypertension—Sibutramine—obesity	8.74e-05	0.000569	CcSEcCtD
Sumatriptan—Dry mouth—Orlistat—obesity	8.71e-05	0.000567	CcSEcCtD
Sumatriptan—Flatulence—Bupropion—obesity	8.69e-05	0.000566	CcSEcCtD
Sumatriptan—Dehydration—Topiramate—obesity	8.68e-05	0.000565	CcSEcCtD
Sumatriptan—Dysgeusia—Bupropion—obesity	8.64e-05	0.000563	CcSEcCtD
Sumatriptan—Liver function test abnormal—Topiramate—obesity	8.62e-05	0.000561	CcSEcCtD
Sumatriptan—Chest pain—Sibutramine—obesity	8.62e-05	0.000561	CcSEcCtD
Sumatriptan—Arthralgia—Sibutramine—obesity	8.62e-05	0.000561	CcSEcCtD
Sumatriptan—Myalgia—Sibutramine—obesity	8.62e-05	0.000561	CcSEcCtD
Sumatriptan—Anxiety—Sibutramine—obesity	8.59e-05	0.000559	CcSEcCtD
Sumatriptan—Oedema—Orlistat—obesity	8.53e-05	0.000556	CcSEcCtD
Sumatriptan—Anaphylactic shock—Orlistat—obesity	8.53e-05	0.000556	CcSEcCtD
Sumatriptan—Back pain—Bupropion—obesity	8.53e-05	0.000556	CcSEcCtD
Sumatriptan—Discomfort—Sibutramine—obesity	8.51e-05	0.000555	CcSEcCtD
Sumatriptan—Muscle spasms—Bupropion—obesity	8.48e-05	0.000553	CcSEcCtD
Sumatriptan—Infection—Orlistat—obesity	8.48e-05	0.000552	CcSEcCtD
Sumatriptan—Dry mouth—Sibutramine—obesity	8.43e-05	0.000549	CcSEcCtD
Sumatriptan—Nervous system disorder—Orlistat—obesity	8.37e-05	0.000545	CcSEcCtD
Sumatriptan—Confusional state—Sibutramine—obesity	8.33e-05	0.000543	CcSEcCtD
Sumatriptan—Skin disorder—Orlistat—obesity	8.29e-05	0.00054	CcSEcCtD
Sumatriptan—Tremor—Bupropion—obesity	8.27e-05	0.000538	CcSEcCtD
Sumatriptan—Gastritis—Topiramate—obesity	8.26e-05	0.000538	CcSEcCtD
Sumatriptan—Anaphylactic shock—Sibutramine—obesity	8.26e-05	0.000538	CcSEcCtD
Sumatriptan—Oedema—Sibutramine—obesity	8.26e-05	0.000538	CcSEcCtD
Sumatriptan—Hyperhidrosis—Orlistat—obesity	8.25e-05	0.000537	CcSEcCtD
Sumatriptan—Infection—Sibutramine—obesity	8.21e-05	0.000535	CcSEcCtD
Sumatriptan—Ill-defined disorder—Bupropion—obesity	8.19e-05	0.000533	CcSEcCtD
Sumatriptan—Anaemia—Bupropion—obesity	8.15e-05	0.000531	CcSEcCtD
Sumatriptan—Shock—Sibutramine—obesity	8.13e-05	0.000529	CcSEcCtD
Sumatriptan—Abdominal distension—Topiramate—obesity	8.12e-05	0.000529	CcSEcCtD
Sumatriptan—Agitation—Bupropion—obesity	8.11e-05	0.000528	CcSEcCtD
Sumatriptan—Thrombocytopenia—Sibutramine—obesity	8.09e-05	0.000527	CcSEcCtD
Sumatriptan—Dysphagia—Topiramate—obesity	8.07e-05	0.000526	CcSEcCtD
Sumatriptan—Asthma—Topiramate—obesity	8.07e-05	0.000526	CcSEcCtD
Sumatriptan—Angioedema—Bupropion—obesity	8.06e-05	0.000525	CcSEcCtD
Sumatriptan—Tachycardia—Sibutramine—obesity	8.06e-05	0.000525	CcSEcCtD
Sumatriptan—Skin disorder—Sibutramine—obesity	8.02e-05	0.000523	CcSEcCtD
Sumatriptan—Hyperhidrosis—Sibutramine—obesity	7.98e-05	0.00052	CcSEcCtD
Sumatriptan—Malaise—Bupropion—obesity	7.96e-05	0.000518	CcSEcCtD
Sumatriptan—Vertigo—Bupropion—obesity	7.93e-05	0.000516	CcSEcCtD
Sumatriptan—Syncope—Bupropion—obesity	7.91e-05	0.000515	CcSEcCtD
Sumatriptan—Pancreatitis—Topiramate—obesity	7.91e-05	0.000515	CcSEcCtD
Sumatriptan—Angina pectoris—Topiramate—obesity	7.86e-05	0.000512	CcSEcCtD
Sumatriptan—Palpitations—Bupropion—obesity	7.8e-05	0.000508	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Orlistat—obesity	7.78e-05	0.000507	CcSEcCtD
Sumatriptan—Bronchitis—Topiramate—obesity	7.76e-05	0.000505	CcSEcCtD
Sumatriptan—Loss of consciousness—Bupropion—obesity	7.75e-05	0.000505	CcSEcCtD
Sumatriptan—Abdominal discomfort—Topiramate—obesity	7.73e-05	0.000504	CcSEcCtD
Sumatriptan—Hypotension—Sibutramine—obesity	7.72e-05	0.000503	CcSEcCtD
Sumatriptan—Cough—Bupropion—obesity	7.7e-05	0.000502	CcSEcCtD
Sumatriptan—Paraesthesia—Orlistat—obesity	7.66e-05	0.000499	CcSEcCtD
Sumatriptan—Pancytopenia—Topiramate—obesity	7.66e-05	0.000499	CcSEcCtD
Sumatriptan—Convulsion—Bupropion—obesity	7.64e-05	0.000498	CcSEcCtD
Sumatriptan—Hypertension—Bupropion—obesity	7.62e-05	0.000496	CcSEcCtD
Sumatriptan—Dysuria—Topiramate—obesity	7.54e-05	0.000491	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Sibutramine—obesity	7.52e-05	0.00049	CcSEcCtD
Sumatriptan—Arthralgia—Bupropion—obesity	7.51e-05	0.000489	CcSEcCtD
Sumatriptan—Myalgia—Bupropion—obesity	7.51e-05	0.000489	CcSEcCtD
Sumatriptan—Chest pain—Bupropion—obesity	7.51e-05	0.000489	CcSEcCtD
Sumatriptan—Anxiety—Bupropion—obesity	7.49e-05	0.000488	CcSEcCtD
Sumatriptan—Pollakiuria—Topiramate—obesity	7.45e-05	0.000485	CcSEcCtD
Sumatriptan—Discomfort—Bupropion—obesity	7.42e-05	0.000483	CcSEcCtD
Sumatriptan—Decreased appetite—Orlistat—obesity	7.42e-05	0.000483	CcSEcCtD
Sumatriptan—Paraesthesia—Sibutramine—obesity	7.42e-05	0.000483	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Orlistat—obesity	7.37e-05	0.00048	CcSEcCtD
Sumatriptan—Dyspnoea—Sibutramine—obesity	7.36e-05	0.00048	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Topiramate—obesity	7.36e-05	0.00048	CcSEcCtD
Sumatriptan—Fatigue—Orlistat—obesity	7.36e-05	0.000479	CcSEcCtD
Sumatriptan—Dry mouth—Bupropion—obesity	7.35e-05	0.000479	CcSEcCtD
Sumatriptan—Somnolence—Sibutramine—obesity	7.34e-05	0.000478	CcSEcCtD
Sumatriptan—Weight increased—Topiramate—obesity	7.34e-05	0.000478	CcSEcCtD
Sumatriptan—Weight decreased—Topiramate—obesity	7.3e-05	0.000475	CcSEcCtD
Sumatriptan—Pain—Orlistat—obesity	7.3e-05	0.000475	CcSEcCtD
Sumatriptan—Hyperglycaemia—Topiramate—obesity	7.28e-05	0.000474	CcSEcCtD
Sumatriptan—Confusional state—Bupropion—obesity	7.26e-05	0.000473	CcSEcCtD
Sumatriptan—Oedema—Bupropion—obesity	7.2e-05	0.000469	CcSEcCtD
Sumatriptan—Anaphylactic shock—Bupropion—obesity	7.2e-05	0.000469	CcSEcCtD
Sumatriptan—Decreased appetite—Sibutramine—obesity	7.18e-05	0.000468	CcSEcCtD
Sumatriptan—Depression—Topiramate—obesity	7.17e-05	0.000467	CcSEcCtD
Sumatriptan—Infection—Bupropion—obesity	7.15e-05	0.000466	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Sibutramine—obesity	7.13e-05	0.000465	CcSEcCtD
Sumatriptan—Shock—Bupropion—obesity	7.08e-05	0.000461	CcSEcCtD
Sumatriptan—Pain—Sibutramine—obesity	7.06e-05	0.00046	CcSEcCtD
Sumatriptan—Constipation—Sibutramine—obesity	7.06e-05	0.00046	CcSEcCtD
Sumatriptan—Nervous system disorder—Bupropion—obesity	7.06e-05	0.00046	CcSEcCtD
Sumatriptan—Thrombocytopenia—Bupropion—obesity	7.05e-05	0.000459	CcSEcCtD
Sumatriptan—Feeling abnormal—Orlistat—obesity	7.03e-05	0.000458	CcSEcCtD
Sumatriptan—Tachycardia—Bupropion—obesity	7.03e-05	0.000458	CcSEcCtD
Sumatriptan—Skin disorder—Bupropion—obesity	6.99e-05	0.000456	CcSEcCtD
Sumatriptan—Conjunctivitis—Topiramate—obesity	6.99e-05	0.000455	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Orlistat—obesity	6.98e-05	0.000455	CcSEcCtD
Sumatriptan—Hyperhidrosis—Bupropion—obesity	6.96e-05	0.000453	CcSEcCtD
Sumatriptan—Haematuria—Topiramate—obesity	6.86e-05	0.000447	CcSEcCtD
Sumatriptan—Feeling abnormal—Sibutramine—obesity	6.81e-05	0.000443	CcSEcCtD
Sumatriptan—Epistaxis—Topiramate—obesity	6.78e-05	0.000442	CcSEcCtD
Sumatriptan—Urticaria—Orlistat—obesity	6.78e-05	0.000442	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Sibutramine—obesity	6.75e-05	0.00044	CcSEcCtD
Sumatriptan—Sinusitis—Topiramate—obesity	6.75e-05	0.00044	CcSEcCtD
Sumatriptan—Body temperature increased—Orlistat—obesity	6.75e-05	0.000439	CcSEcCtD
Sumatriptan—Abdominal pain—Orlistat—obesity	6.75e-05	0.000439	CcSEcCtD
Sumatriptan—Hypotension—Bupropion—obesity	6.73e-05	0.000438	CcSEcCtD
Sumatriptan—Bradycardia—Topiramate—obesity	6.57e-05	0.000428	CcSEcCtD
Sumatriptan—Urticaria—Sibutramine—obesity	6.56e-05	0.000427	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Bupropion—obesity	6.56e-05	0.000427	CcSEcCtD
Sumatriptan—Abdominal pain—Sibutramine—obesity	6.53e-05	0.000425	CcSEcCtD
Sumatriptan—Body temperature increased—Sibutramine—obesity	6.53e-05	0.000425	CcSEcCtD
Sumatriptan—Haemoglobin—Topiramate—obesity	6.49e-05	0.000423	CcSEcCtD
Sumatriptan—Paraesthesia—Bupropion—obesity	6.47e-05	0.000421	CcSEcCtD
Sumatriptan—Haemorrhage—Topiramate—obesity	6.46e-05	0.000421	CcSEcCtD
Sumatriptan—Hypoaesthesia—Topiramate—obesity	6.42e-05	0.000419	CcSEcCtD
Sumatriptan—Hallucination—Topiramate—obesity	6.42e-05	0.000419	CcSEcCtD
Sumatriptan—Dyspnoea—Bupropion—obesity	6.42e-05	0.000418	CcSEcCtD
Sumatriptan—Somnolence—Bupropion—obesity	6.4e-05	0.000417	CcSEcCtD
Sumatriptan—Connective tissue disorder—Topiramate—obesity	6.35e-05	0.000413	CcSEcCtD
Sumatriptan—Hypersensitivity—Orlistat—obesity	6.29e-05	0.00041	CcSEcCtD
Sumatriptan—Decreased appetite—Bupropion—obesity	6.26e-05	0.000408	CcSEcCtD
Sumatriptan—Visual impairment—Topiramate—obesity	6.22e-05	0.000405	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Bupropion—obesity	6.22e-05	0.000405	CcSEcCtD
Sumatriptan—Fatigue—Bupropion—obesity	6.21e-05	0.000404	CcSEcCtD
Sumatriptan—Pain—Bupropion—obesity	6.16e-05	0.000401	CcSEcCtD
Sumatriptan—Constipation—Bupropion—obesity	6.16e-05	0.000401	CcSEcCtD
Sumatriptan—Asthenia—Orlistat—obesity	6.12e-05	0.000399	CcSEcCtD
Sumatriptan—Hypersensitivity—Sibutramine—obesity	6.09e-05	0.000396	CcSEcCtD
Sumatriptan—Pruritus—Orlistat—obesity	6.04e-05	0.000393	CcSEcCtD
Sumatriptan—Eye disorder—Topiramate—obesity	6.03e-05	0.000393	CcSEcCtD
Sumatriptan—Tinnitus—Topiramate—obesity	6.02e-05	0.000392	CcSEcCtD
Sumatriptan—Flushing—Topiramate—obesity	5.99e-05	0.00039	CcSEcCtD
Sumatriptan—Feeling abnormal—Bupropion—obesity	5.93e-05	0.000387	CcSEcCtD
Sumatriptan—Asthenia—Sibutramine—obesity	5.93e-05	0.000386	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Bupropion—obesity	5.89e-05	0.000384	CcSEcCtD
Sumatriptan—Angiopathy—Topiramate—obesity	5.86e-05	0.000382	CcSEcCtD
Sumatriptan—Pruritus—Sibutramine—obesity	5.84e-05	0.000381	CcSEcCtD
Sumatriptan—Diarrhoea—Orlistat—obesity	5.84e-05	0.00038	CcSEcCtD
Sumatriptan—Immune system disorder—Topiramate—obesity	5.83e-05	0.00038	CcSEcCtD
Sumatriptan—Mediastinal disorder—Topiramate—obesity	5.82e-05	0.000379	CcSEcCtD
Sumatriptan—Chills—Topiramate—obesity	5.79e-05	0.000377	CcSEcCtD
Sumatriptan—Urticaria—Bupropion—obesity	5.72e-05	0.000373	CcSEcCtD
Sumatriptan—Abdominal pain—Bupropion—obesity	5.69e-05	0.000371	CcSEcCtD
Sumatriptan—Body temperature increased—Bupropion—obesity	5.69e-05	0.000371	CcSEcCtD
Sumatriptan—Diarrhoea—Sibutramine—obesity	5.65e-05	0.000368	CcSEcCtD
Sumatriptan—Dizziness—Orlistat—obesity	5.64e-05	0.000368	CcSEcCtD
Sumatriptan—Erythema—Topiramate—obesity	5.62e-05	0.000366	CcSEcCtD
Sumatriptan—Flatulence—Topiramate—obesity	5.54e-05	0.000361	CcSEcCtD
Sumatriptan—Dysgeusia—Topiramate—obesity	5.5e-05	0.000359	CcSEcCtD
Sumatriptan—Dizziness—Sibutramine—obesity	5.46e-05	0.000356	CcSEcCtD
Sumatriptan—Back pain—Topiramate—obesity	5.44e-05	0.000354	CcSEcCtD
Sumatriptan—Vomiting—Orlistat—obesity	5.43e-05	0.000353	CcSEcCtD
Sumatriptan—Muscle spasms—Topiramate—obesity	5.4e-05	0.000352	CcSEcCtD
Sumatriptan—Rash—Orlistat—obesity	5.38e-05	0.000351	CcSEcCtD
Sumatriptan—Dermatitis—Orlistat—obesity	5.38e-05	0.00035	CcSEcCtD
Sumatriptan—Headache—Orlistat—obesity	5.35e-05	0.000348	CcSEcCtD
Sumatriptan—Hypersensitivity—Bupropion—obesity	5.3e-05	0.000346	CcSEcCtD
Sumatriptan—Tremor—Topiramate—obesity	5.27e-05	0.000343	CcSEcCtD
Sumatriptan—Vomiting—Sibutramine—obesity	5.25e-05	0.000342	CcSEcCtD
Sumatriptan—Ill-defined disorder—Topiramate—obesity	5.22e-05	0.00034	CcSEcCtD
Sumatriptan—Rash—Sibutramine—obesity	5.21e-05	0.000339	CcSEcCtD
Sumatriptan—Dermatitis—Sibutramine—obesity	5.2e-05	0.000339	CcSEcCtD
Sumatriptan—Anaemia—Topiramate—obesity	5.2e-05	0.000338	CcSEcCtD
Sumatriptan—Headache—Sibutramine—obesity	5.17e-05	0.000337	CcSEcCtD
Sumatriptan—Asthenia—Bupropion—obesity	5.17e-05	0.000337	CcSEcCtD
Sumatriptan—Agitation—Topiramate—obesity	5.17e-05	0.000336	CcSEcCtD
Sumatriptan—Pruritus—Bupropion—obesity	5.09e-05	0.000332	CcSEcCtD
Sumatriptan—Nausea—Orlistat—obesity	5.07e-05	0.00033	CcSEcCtD
Sumatriptan—Malaise—Topiramate—obesity	5.07e-05	0.00033	CcSEcCtD
Sumatriptan—Vertigo—Topiramate—obesity	5.05e-05	0.000329	CcSEcCtD
Sumatriptan—Syncope—Topiramate—obesity	5.04e-05	0.000328	CcSEcCtD
Sumatriptan—Palpitations—Topiramate—obesity	4.97e-05	0.000324	CcSEcCtD
Sumatriptan—Loss of consciousness—Topiramate—obesity	4.94e-05	0.000322	CcSEcCtD
Sumatriptan—Diarrhoea—Bupropion—obesity	4.93e-05	0.000321	CcSEcCtD
Sumatriptan—Nausea—Sibutramine—obesity	4.91e-05	0.00032	CcSEcCtD
Sumatriptan—Cough—Topiramate—obesity	4.9e-05	0.00032	CcSEcCtD
Sumatriptan—Convulsion—Topiramate—obesity	4.87e-05	0.000317	CcSEcCtD
Sumatriptan—Hypertension—Topiramate—obesity	4.85e-05	0.000316	CcSEcCtD
Sumatriptan—Arthralgia—Topiramate—obesity	4.79e-05	0.000312	CcSEcCtD
Sumatriptan—Myalgia—Topiramate—obesity	4.79e-05	0.000312	CcSEcCtD
Sumatriptan—Chest pain—Topiramate—obesity	4.79e-05	0.000312	CcSEcCtD
Sumatriptan—Anxiety—Topiramate—obesity	4.77e-05	0.000311	CcSEcCtD
Sumatriptan—Dizziness—Bupropion—obesity	4.76e-05	0.00031	CcSEcCtD
Sumatriptan—Discomfort—Topiramate—obesity	4.73e-05	0.000308	CcSEcCtD
Sumatriptan—Dry mouth—Topiramate—obesity	4.68e-05	0.000305	CcSEcCtD
Sumatriptan—Confusional state—Topiramate—obesity	4.63e-05	0.000301	CcSEcCtD
Sumatriptan—Oedema—Topiramate—obesity	4.59e-05	0.000299	CcSEcCtD
Sumatriptan—Vomiting—Bupropion—obesity	4.58e-05	0.000298	CcSEcCtD
Sumatriptan—Infection—Topiramate—obesity	4.56e-05	0.000297	CcSEcCtD
Sumatriptan—Rash—Bupropion—obesity	4.54e-05	0.000296	CcSEcCtD
Sumatriptan—Dermatitis—Bupropion—obesity	4.54e-05	0.000295	CcSEcCtD
Sumatriptan—Shock—Topiramate—obesity	4.51e-05	0.000294	CcSEcCtD
Sumatriptan—Headache—Bupropion—obesity	4.51e-05	0.000294	CcSEcCtD
Sumatriptan—Nervous system disorder—Topiramate—obesity	4.5e-05	0.000293	CcSEcCtD
Sumatriptan—Thrombocytopenia—Topiramate—obesity	4.49e-05	0.000293	CcSEcCtD
Sumatriptan—Tachycardia—Topiramate—obesity	4.48e-05	0.000292	CcSEcCtD
Sumatriptan—Skin disorder—Topiramate—obesity	4.46e-05	0.00029	CcSEcCtD
Sumatriptan—Hyperhidrosis—Topiramate—obesity	4.43e-05	0.000289	CcSEcCtD
Sumatriptan—Hypotension—Topiramate—obesity	4.29e-05	0.000279	CcSEcCtD
Sumatriptan—Nausea—Bupropion—obesity	4.28e-05	0.000279	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Topiramate—obesity	4.18e-05	0.000272	CcSEcCtD
Sumatriptan—Paraesthesia—Topiramate—obesity	4.12e-05	0.000268	CcSEcCtD
Sumatriptan—Dyspnoea—Topiramate—obesity	4.09e-05	0.000266	CcSEcCtD
Sumatriptan—Somnolence—Topiramate—obesity	4.08e-05	0.000266	CcSEcCtD
Sumatriptan—Decreased appetite—Topiramate—obesity	3.99e-05	0.00026	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Topiramate—obesity	3.96e-05	0.000258	CcSEcCtD
Sumatriptan—Fatigue—Topiramate—obesity	3.95e-05	0.000258	CcSEcCtD
Sumatriptan—Constipation—Topiramate—obesity	3.92e-05	0.000256	CcSEcCtD
Sumatriptan—Pain—Topiramate—obesity	3.92e-05	0.000256	CcSEcCtD
Sumatriptan—Feeling abnormal—Topiramate—obesity	3.78e-05	0.000246	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Topiramate—obesity	3.75e-05	0.000244	CcSEcCtD
Sumatriptan—Urticaria—Topiramate—obesity	3.64e-05	0.000237	CcSEcCtD
Sumatriptan—Abdominal pain—Topiramate—obesity	3.63e-05	0.000236	CcSEcCtD
Sumatriptan—Body temperature increased—Topiramate—obesity	3.63e-05	0.000236	CcSEcCtD
Sumatriptan—Hypersensitivity—Topiramate—obesity	3.38e-05	0.00022	CcSEcCtD
Sumatriptan—Asthenia—Topiramate—obesity	3.29e-05	0.000214	CcSEcCtD
Sumatriptan—Pruritus—Topiramate—obesity	3.25e-05	0.000211	CcSEcCtD
Sumatriptan—Diarrhoea—Topiramate—obesity	3.14e-05	0.000204	CcSEcCtD
Sumatriptan—Dizziness—Topiramate—obesity	3.03e-05	0.000198	CcSEcCtD
Sumatriptan—Vomiting—Topiramate—obesity	2.92e-05	0.00019	CcSEcCtD
Sumatriptan—Rash—Topiramate—obesity	2.89e-05	0.000188	CcSEcCtD
Sumatriptan—Dermatitis—Topiramate—obesity	2.89e-05	0.000188	CcSEcCtD
Sumatriptan—Headache—Topiramate—obesity	2.87e-05	0.000187	CcSEcCtD
Sumatriptan—Nausea—Topiramate—obesity	2.72e-05	0.000178	CcSEcCtD
Sumatriptan—ABCG2—Metabolism—APOE—obesity	3.43e-06	3.27e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—INS—obesity	3.43e-06	3.27e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IRS1—obesity	3.42e-06	3.25e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LPL—obesity	3.41e-06	3.24e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKR1C3—obesity	3.41e-06	3.24e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CAV1—obesity	3.4e-06	3.24e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SOCS1—obesity	3.4e-06	3.23e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ALB—obesity	3.4e-06	3.23e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOA1—obesity	3.39e-06	3.23e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CG—obesity	3.38e-06	3.22e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FOXO1—obesity	3.38e-06	3.22e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RPS6KB1—obesity	3.38e-06	3.21e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CD—obesity	3.37e-06	3.2e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SOCS3—obesity	3.36e-06	3.19e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SCARB1—obesity	3.35e-06	3.19e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CG—obesity	3.35e-06	3.18e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IRS1—obesity	3.34e-06	3.18e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CB—obesity	3.34e-06	3.18e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—POMC—obesity	3.29e-06	3.13e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GNB3—obesity	3.29e-06	3.13e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—INS—obesity	3.27e-06	3.11e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SREBF1—obesity	3.25e-06	3.1e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3R1—obesity	3.25e-06	3.09e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NOS3—obesity	3.25e-06	3.09e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TYK2—obesity	3.24e-06	3.08e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CB—obesity	3.23e-06	3.08e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PPARG—obesity	3.23e-06	3.07e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF2—obesity	3.23e-06	3.07e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—POMC—obesity	3.22e-06	3.06e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCL2—obesity	3.22e-06	3.06e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RHOA—obesity	3.21e-06	3.06e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—INS—obesity	3.2e-06	3.05e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—STAT3—obesity	3.2e-06	3.04e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GNAS—obesity	3.2e-06	3.04e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CD—obesity	3.19e-06	3.03e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—POMC—obesity	3.19e-06	3.03e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3R1—obesity	3.18e-06	3.03e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—INS—obesity	3.17e-06	3.01e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GOT2—obesity	3.17e-06	3.01e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1—obesity	3.16e-06	3.01e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT2—obesity	3.16e-06	3.01e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL2—obesity	3.15e-06	3e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ALB—obesity	3.15e-06	2.99e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRKCD—obesity	3.14e-06	2.99e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOB—obesity	3.13e-06	2.98e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ALB—obesity	3.1e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—FASN—obesity	3.1e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CG—obesity	3.1e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1—obesity	3.1e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT2—obesity	3.1e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—BCHE—obesity	3.09e-06	2.94e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR2A—obesity	3.07e-06	2.92e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—C3—obesity	3.07e-06	2.92e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL5—obesity	3.06e-06	2.91e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CD—obesity	3.04e-06	2.89e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NOS3—obesity	3.01e-06	2.86e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3R1—obesity	3.01e-06	2.86e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—PIK3CA—obesity	3.01e-06	2.86e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SERPINE1—obesity	3e-06	2.86e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CB—obesity	3e-06	2.85e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LPL—obesity	2.99e-06	2.85e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARG—obesity	2.99e-06	2.85e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP2E1—obesity	2.98e-06	2.83e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CD—obesity	2.97e-06	2.83e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—obesity	2.97e-06	2.83e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—obesity	2.97e-06	2.83e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FOXO1—obesity	2.97e-06	2.83e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFB1—obesity	2.97e-06	2.82e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RPS6KB1—obesity	2.96e-06	2.82e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—POMC—obesity	2.95e-06	2.81e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PIK3CA—obesity	2.95e-06	2.8e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NQO1—obesity	2.94e-06	2.8e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SERPINE1—obesity	2.94e-06	2.8e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CD—obesity	2.94e-06	2.8e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CB—obesity	2.94e-06	2.79e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—INS—obesity	2.93e-06	2.79e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TYK2—obesity	2.92e-06	2.78e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IRS2—obesity	2.92e-06	2.78e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AGT—obesity	2.91e-06	2.77e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—obesity	2.9e-06	2.76e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RHOA—obesity	2.9e-06	2.76e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NOS3—obesity	2.87e-06	2.73e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3R1—obesity	2.87e-06	2.73e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TYK2—obesity	2.86e-06	2.72e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LEP—obesity	2.86e-06	2.72e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOE—obesity	2.86e-06	2.72e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RHOA—obesity	2.84e-06	2.7e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CAV1—obesity	2.83e-06	2.69e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOA1—obesity	2.82e-06	2.69e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC2A4—obesity	2.82e-06	2.69e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GCG—obesity	2.82e-06	2.69e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3R1—obesity	2.81e-06	2.67e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NOS3—obesity	2.81e-06	2.67e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYCS—obesity	2.79e-06	2.65e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CB—obesity	2.78e-06	2.64e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3R1—obesity	2.78e-06	2.64e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NOS3—obesity	2.78e-06	2.64e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKCD—obesity	2.76e-06	2.62e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—obesity	2.75e-06	2.62e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GOT1—obesity	2.73e-06	2.6e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GGT1—obesity	2.73e-06	2.6e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PIK3CA—obesity	2.73e-06	2.6e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ESR1—obesity	2.73e-06	2.59e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CD—obesity	2.72e-06	2.59e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR2A—obesity	2.7e-06	2.57e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—C3—obesity	2.69e-06	2.56e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—F2—obesity	2.69e-06	2.56e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRKCB—obesity	2.69e-06	2.56e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NCOA1—obesity	2.69e-06	2.56e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—obesity	2.69e-06	2.56e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PIK3CA—obesity	2.68e-06	2.55e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BAD—obesity	2.66e-06	2.53e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—STK11—obesity	2.65e-06	2.52e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP19A1—obesity	2.65e-06	2.52e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CB—obesity	2.65e-06	2.52e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MTOR—obesity	2.65e-06	2.52e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CB—obesity	2.59e-06	2.47e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MTOR—obesity	2.59e-06	2.47e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CG—obesity	2.58e-06	2.45e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NOS3—obesity	2.57e-06	2.45e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3R1—obesity	2.57e-06	2.45e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CB—obesity	2.56e-06	2.44e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IRS2—obesity	2.56e-06	2.44e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AGT—obesity	2.56e-06	2.43e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IRS1—obesity	2.55e-06	2.42e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—obesity	2.54e-06	2.42e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CA—obesity	2.52e-06	2.4e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOE—obesity	2.51e-06	2.39e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LEP—obesity	2.51e-06	2.39e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CAV1—obesity	2.48e-06	2.36e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOA1—obesity	2.48e-06	2.36e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—COMT—obesity	2.47e-06	2.35e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AKT1—obesity	2.46e-06	2.34e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—POMC—obesity	2.45e-06	2.33e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—INS—obesity	2.44e-06	2.32e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GNB3—obesity	2.43e-06	2.31e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARGC1A—obesity	2.43e-06	2.31e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HMOX1—obesity	2.42e-06	2.3e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—obesity	2.42e-06	2.3e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AKT1—obesity	2.41e-06	2.29e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL2—obesity	2.4e-06	2.28e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ESR1—obesity	2.39e-06	2.28e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CB—obesity	2.37e-06	2.26e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—obesity	2.37e-06	2.25e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GNAS—obesity	2.37e-06	2.25e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—F2—obesity	2.36e-06	2.25e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKCB—obesity	2.36e-06	2.25e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1—obesity	2.36e-06	2.25e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT2—obesity	2.36e-06	2.24e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—obesity	2.35e-06	2.24e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BAD—obesity	2.34e-06	2.22e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOB—obesity	2.32e-06	2.21e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—obesity	2.3e-06	2.19e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CD—obesity	2.27e-06	2.16e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CG—obesity	2.26e-06	2.15e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—obesity	2.25e-06	2.14e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CA—obesity	2.24e-06	2.14e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SERPINE1—obesity	2.24e-06	2.13e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK8—obesity	2.24e-06	2.13e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IRS1—obesity	2.24e-06	2.13e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—obesity	2.23e-06	2.13e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AKT1—obesity	2.23e-06	2.12e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—LPL—obesity	2.21e-06	2.11e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK8—obesity	2.19e-06	2.09e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AKT1—obesity	2.19e-06	2.08e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TYK2—obesity	2.18e-06	2.07e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RHOA—obesity	2.16e-06	2.06e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPX1—obesity	2.16e-06	2.06e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—POMC—obesity	2.15e-06	2.05e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—INS—obesity	2.14e-06	2.04e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3R1—obesity	2.14e-06	2.04e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NOS3—obesity	2.14e-06	2.04e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL2—obesity	2.11e-06	2.01e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CD36—obesity	2.1e-06	2e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1—obesity	2.07e-06	1.97e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT2—obesity	2.07e-06	1.97e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKT1—obesity	2.06e-06	1.96e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT3—obesity	2.05e-06	1.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CA—obesity	2.04e-06	1.94e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT3—obesity	2e-06	1.91e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—obesity	1.99e-06	1.9e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CD—obesity	1.99e-06	1.89e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CB—obesity	1.97e-06	1.88e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MTOR—obesity	1.97e-06	1.88e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CA—obesity	1.97e-06	1.87e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SERPINE1—obesity	1.97e-06	1.87e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARA—obesity	1.96e-06	1.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TYK2—obesity	1.91e-06	1.82e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—obesity	1.9e-06	1.81e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RHOA—obesity	1.9e-06	1.81e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFB1—obesity	1.9e-06	1.8e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AGT—obesity	1.89e-06	1.8e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOS3—obesity	1.88e-06	1.79e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3R1—obesity	1.88e-06	1.79e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—obesity	1.86e-06	1.77e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFB1—obesity	1.86e-06	1.77e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOE—obesity	1.86e-06	1.77e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAV1—obesity	1.84e-06	1.75e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOA1—obesity	1.83e-06	1.75e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AKT1—obesity	1.83e-06	1.74e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CA—obesity	1.83e-06	1.74e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—obesity	1.8e-06	1.72e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CA—obesity	1.79e-06	1.7e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MTOR—obesity	1.73e-06	1.65e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CB—obesity	1.73e-06	1.65e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—obesity	1.72e-06	1.63e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CA—obesity	1.69e-06	1.61e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CG—obesity	1.68e-06	1.59e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK8—obesity	1.67e-06	1.59e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AKT1—obesity	1.66e-06	1.58e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARG—obesity	1.62e-06	1.54e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CA—obesity	1.61e-06	1.54e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AKT1—obesity	1.61e-06	1.53e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—POMC—obesity	1.59e-06	1.52e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—INS—obesity	1.59e-06	1.51e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—obesity	1.58e-06	1.51e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CA—obesity	1.58e-06	1.5e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CA—obesity	1.56e-06	1.49e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT3—obesity	1.53e-06	1.45e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—obesity	1.51e-06	1.43e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AKT1—obesity	1.49e-06	1.42e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CD—obesity	1.47e-06	1.4e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK8—obesity	1.47e-06	1.39e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT1—obesity	1.46e-06	1.39e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—obesity	1.45e-06	1.38e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CA—obesity	1.45e-06	1.38e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—obesity	1.43e-06	1.36e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—obesity	1.42e-06	1.35e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFB1—obesity	1.41e-06	1.35e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—obesity	1.4e-06	1.33e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3R1—obesity	1.39e-06	1.32e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NOS3—obesity	1.39e-06	1.32e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AKT1—obesity	1.38e-06	1.32e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT3—obesity	1.34e-06	1.28e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT1—obesity	1.32e-06	1.25e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT1—obesity	1.29e-06	1.23e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CB—obesity	1.28e-06	1.22e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AKT1—obesity	1.28e-06	1.21e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—obesity	1.27e-06	1.21e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—obesity	1.25e-06	1.18e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFB1—obesity	1.24e-06	1.18e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CA—obesity	1.2e-06	1.15e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AKT1—obesity	1.18e-06	1.13e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—obesity	1.07e-06	1.01e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CA—obesity	1.06e-06	1.01e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT1—obesity	9.84e-07	9.36e-06	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—obesity	9.36e-07	8.91e-06	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT1—obesity	8.64e-07	8.22e-06	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CA—obesity	7.83e-07	7.45e-06	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKT1—obesity	6.39e-07	6.08e-06	CbGpPWpGaD
